RS
Roivant Sciences Ltd.
ROIV· Health Care· BiotechnologyS&P 400
Close · 26/10/2026
36.05
1D
-1.21%52-week range
17.89 – 42.5
Volume
98,68,500.00
Price history
ROIV
25/09/2026 to 26/10/2026
O 36.66 H 36.91 L 35.66
1W+3.89%
1M+0.70%
3M+6.53%
6M+29.44%
1Y+98.95%
3Y+268.99%
5Y+515.19%
MAX+263.41%
Fundamentals
as of 26/10/2026- Market cap
- $26.04B
- Shares out
- 722.32M
- P/E (forward)
- -21.24
- EPS (trailing)
- -0.37
- Dividend yield
- 0.00%
- Beta
- 1.10
- Profit margin
- -3534.96%
- P/B
- 6.15
- Return on equity
- -6.29%
SEC financial statements
19 quarterly and 6 annual periods through 30/06/2026.
Details
- Ticker
- ROIV
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 26/10/2026.
Tracked by Congress
1 filer · 0 on watchlist · 2 buys · 2 sells · R: 4
- 31/10/2025Lisa McClainSellRoivant Sciences Ltd. - Common Shares$1,001–$15,000
- 30/10/2025Lisa McClainSellRoivant Sciences Ltd. - Common Shares$1,001–$15,000
- 30/10/2025Lisa McClainBuyRoivant Sciences Ltd. - Common Shares$1,001–$15,000
- 17/06/2025Lisa McClainBuyRoivant Sciences Ltd. - Common Shares$1,001–$15,000